Abstract

Parkinson’s disease (PD) is an aging-related degenerative disorder arisen from the loss of dopaminergic neurons in substantia nigra. Although many genetic mutations have been implicated to be genetically linked to PD, the low incidence of familial PD carried with mutations suggests that there must be other factors such as oxidative stress, mitochondrial dysfunction, accumulation of misfolded proteins, and enhanced inflammation, which are contributable to the pathophysiology of PD. The major efforts of current research have been devoted to unravel the toxic effect of multiple factors, which directly cause the degeneration of dopaminergic neurons in adulthood. Until recently, several studies have demonstrated that NSCs had compromised proliferation and differentiation capacity in PD animal models or PD patient-derived iPS models, suggesting that the pathology of PD may be rooted in some cellular aberrations at early developmental stage but the mechanism remains to be elusive. Based on the early-onset PD patient-specific iPSCs, we found that PD-patient iPSC-derived NSCs were more susceptible to stress and became functionally compromised by radiation or oxidative insults. We further unraveled that stress-induced SIRT1 downregulation leading to autophagic dysfunction, which were responsible for these deficits in PD-NSCs. Mechanistically, we demonstrated that stress-induced activation of p38 MAPK suppressed SIRT1 expression, which in turn augmented the acetylation of multiple ATG proteins of autophagic complex and eventually led to autophagic deficits. Our studies suggest that early developmental deficits may, at least partially, contribute to the pathology of PD and provide a new avenue for developing better therapeutic interventions to PD.

Highlights

  • Parkinson’s disease (PD) is one of the most common neurodegenerative diseases, which is characterized by movement abnormalities of PD patients such as tremor, rigidity, bradykinesia, and gait dysfunction[1]

  • We found a potentially deleterious splice-site mutation c.292-1G > A within Parkin co-regulated gene (PACRG) in PD-S-fibroblasts (Fig. S1b), which derived from the 21-year-old PD patient, leading to an abnormal splice-site variants

  • The deficiency in LRRK2, VPS35, SNCA, and PINK1 led to deregulated embryonic neurogenesis and neurite outgrowth[37,38,39,40]

Read more

Summary

Introduction

Parkinson’s disease (PD) is one of the most common neurodegenerative diseases, which is characterized by movement abnormalities of PD patients such as tremor, rigidity, bradykinesia, and gait dysfunction[1]. Official journal of the Cell Death Differentiation Association. Zhu et al Cell Death and Disease (2019)10:105 sporadic PD iPSC lines as well as their isogenic control lines by gene-editing, have been generated and provide insightful clues regarding the mechanism of the disease[8,9]. It is worthy of notice that some studies reported that PD iPSCs manifested early developmental defects at the stage of neural stem cells (NSCs)[10]. Several studies in mouse models have proved that NSCs carrying the SNCA mutation showed reduced proliferation, impaired neurogenesis, and increased cell death[11,12,13,14]. NSCs from transgenic mice expressing mutant LRRK2 exhibited deficient proliferation and reduced newborn neurons[15,16]. It is likely that insults, which lead to the degeneration of DA neurons may root at the very beginning of CNS development

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call